Jan Westerblad
Norwegian & Danish ExpertJan has extensive practical experience in the field of rare/ultra-rare disease
Jan started in the pharmaceutical industry in the early 1990s and since the beginning of the early 2000’s, his focus has been in the field of orphan/ultraorphan disease. As Country Manager/General Manager, he has been involved/responsible for starting up Norwegian/Nordic commercial operations in several rare disease companies where he planned and executed commercialization strategies while building a strong scientific and commercial presence. Lately, as a consultant, specializing in market access and public affairs, Jan has been advising companies on the importance of comprehensive market access strategies with early and diverse stakeholder involvement to successfully bring new therapies to patients with unmet medical needs.